July 25, 2014 12:59 PM ET

Biotechnology

Company Overview of POINT Biomedical Corp.

Executive Profile

Thomas L. Feldman

President and Chief Business Officer, CoTherix, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 3 different industries.

63--

Background

Mr. Thomas L. Feldman, also known as Tom, served as Chief Executive Officer and President of POINT Biomedical Corp. Prior to, Mr. Feldman served as President and Chief Business Officer of CoTherix Inc. since August 2004. He also served as Chief Commercial Officer of CoTherix Inc. from December 2003 to August 2004 and also as its Executive Vice President. From 1995 to November 14, 2002, he served as Vice President of Sales and Marketing at Scios, Inc. Mr. Feldman started ...

Corporate Headquarters

887L Industrial Road
San Carlos, California 94070

United States

Phone: 650-596-1400
Fax: 650-596-1402

Board Members Memberships

2007-N/A
Chief Executive Officer, President and Director

Education

Unknown/Other Education
North Dakota State University
BS
North Dakota State University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact POINT Biomedical Corp., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.